• • Advanced cancer pain is still reported as common, severe and undertreated.
What is already known about the topic?
• • Advanced cancer pain is still reported as common, severe and undertreated.
• • Patients' attitudes and beliefs impinge on use of medications, particularly morphine, to manage pain.
What this paper adds?
• • The dynamic, complex and multi-dimensional nature of pain presents a major challenge for patients and professionals to manage it and to secure good enough relief. • • Although attitudes and beliefs towards analgesics vary, they do not drive patient behaviour. Rather, patients' sensory experiences of pain, particularly severity, and its meaning shaped behaviour with consequences for how pain was managed. • • The multi-dimensional nature of pain meant that many patients were taking a wide range of pain medications, that is, non-opioid analgesics, compound analgesics, slow-release opioids and anticonvulsants. The acceptability of rescue morphine varied depending on patients' sensory experiences of pain.
Introduction
Pain continues to be a major source of suffering in advanced cancer with adverse effects on patients' life quality [1] [2] [3] and caregiver distress. [4] [5] [6] A meta-analysis of pain prevalence 7 found a rate of 64% among advanced cancer patients, of whom more than one-third graded their pain as moderate or severe. There is increasing recognition of the complexity and multi-dimensionality of pain. It varies in type, source, intensity, duration and site, is experienced singularly or in combination, and is imbued with meaning. 8 This includes different types of pain such as neuropathic, 9 incident or breakthrough, 2 and bone pain 10 associated with poor pain control and with negative impact on physical, cognitive and social functioning and mood. Furthermore, since these types of pain are both disease-and treatment-related, expansion of new treatment modalities that extend life, thus lengthening the advanced trajectory stage, means that prevalence of complex pain is likely to increase. 11 The meaning and consequences of the multi-dimensional nature of pain in advanced cancer and the differential responsiveness of varying types of pain to opioid analgesia 9, 12 have not thus far informed understanding of how patients manage their pain. Additionally, the lengthening of the advanced cancer trajectory and increased risk of complex pain create new challenges for patients in managing it. However, from the perspective of patients, the literature typically construes cancer pain as singular, linear, cumulative in nature and inevitable as death approaches. 13 At the same time, research interest has primarily focused on under-treatment of cancer pain, and particularly on the attitudes and beliefs of patients that impinge negatively on medication adherence generally and on morphine specifically. [13] [14] [15] Reported in systematic reviews 16, 17 and qualitative synthesis, 18 these include fear of addiction and side effects, the desire to be seen as a 'good patient', beliefs that pain signifies progression of the cancer and that pain is inevitable. The underpinning theory is that attitudes and beliefs inform behaviour and lead to poor adherence to medication regimens that in turn give rise to sub-optimal pain relief. While this theory has informed research on educational interventions to tackle sub-optimal pain management practices, a recent review of reviews concluded that although such interventions can have a very small impact on pain intensity, their clinical significance is questionable. 19 There is a considerable knowledge gap between the conception of pain in the medical literature as complex and heterogeneous and the processes whereby patients with advanced cancer experience, understand and manage pain in everyday life.
Aim
The aim of this study was to examine how patients with advanced cancer and their caregivers experienced pain complexity, the meaning they attached to it, how they managed it and what shaped their perspectives and actions. It thus provides insight into an important theoretical and practical gap in current understanding of cancer pain.
Methods
We employed a qualitative interpretive approach. The study was conducted in two service settings in a Northern English city -oncology outpatients' clinics within a tertiary cancer centre and a hospice palliative care service. It was part of a research programme on the management of advanced cancer pain. Research ethics committee approval was obtained (National Research Ethics Service (NRES) Committee South West -Cornwall & Plymouth; 12/ SW/0287).
Participants
Inclusion criteria were as follows: experiencing pain, living at home, over the age of 25 years, with advanced cancer (defined as active and non-curative). Purposive sampling was used to identify patients at different points in the disease course with different types of cancer. Further, by recruiting patients from oncology and palliative care services, our assumption was that this would ensure inclusion of individuals at different stages of advanced disease. Patients were initially approached by oncologists and research nurses from out-patient clinics in eight speciality cancer areas (lung, breast, colorectal, head and neck, prostate, gynaecological, upper gastrointestinal (GI) and renal) and by clinical nurse specialists for those receiving palliative care services. Following expressions of interest, the first author (J.H.) discussed participation with interested individuals in person or by telephone and obtained informed consent.
Data collection
In-depth, face-to-face interviews were carried out at two time points, 6 weeks apart to capture change over time. These were a combination of dyadic (patients and their caregiver together) and individual interviews, conducted primarily by J.H., mainly in patients' homes. Dyadic interviews sought to explore the collective, inter-dependent perspective of patient and caregiver in pain understanding and management. 20, 21 Interviews were guided conversations to elicit accounts of participants' experience in their own words at a pace determined by them, using a topic guide (Appendix 1). This was used flexibly as an aide memoire to discuss experience of illness and pain. Second interviews incorporated specific prompts to pursue analytic ideas, for example, transitions in the pain experience and how these were managed. A sub-sample of patients were selected based on their varied experiences of pain and asked to complete an audio diary in-between interviews to obtain a contemporaneous picture of pain and the response to it.
Data analysis
Interviews and audio diaries were transcribed, and participants chose a pseudonym. Data were collected from April 2013 to January 2014.
We adopted a grounded theory analytic approach. 22, 23 This combined concurrent data collection and analysis with modification to the topic guide to pursue emerging lines of inquiry. Debrief meetings involving the first two authors (J.H. and M.G.) took place and were recorded after each interview. They provided space to reflect on the interview process, emotional content and effect on the researcher, and to explore initial ideas about the data. Further phases carried out by J.H. and M.G., separately and together, were familiarisation through multiple readings of transcripts, and then open and focused coding and memo-writing to facilitate the development of categories and concepts. Method of constant comparison was used throughout, whereby data segments and the developing codes and categories were compared both within cases to identify the temporal sequencing of events, and how these were understood and acted upon, and between cases to examine variation between participants. For example, having developed the analytic categories of pain type and their properties (complexity, intensity and controllability), we examined their consequences in terms of subjective meaning and the work of pain management for patients and caregivers. Throughout data collection and analysis, data, codes and concepts were discussed within the research team (of varied disciplinary backgrounds, psychology, sociology and academic palliative care medicine) and with the wider steering group. The latter included patient representatives, clinicians and academics. NVivo10 was used to support the analysis.
Results
In all, 24 patients and 18 carers were recruited. Of these, 16 patient/carer dyads and 5 patients alone completed a first interview; 3 patients withdrew on account of deteriorating illness. Totally, 11 patient/carer dyads and 3 patients alone completed the second interview; 3 had died and 4 were too unwell to participate. We did not seek to interview caregivers following the death of their relative. Three patients completed the audio diary. In all, 35 interviews were conducted (27 patient/caregiver dyads; average interview length was around an hour (range: 45-130 min)). Table 1 provides a profile of patients. All were White British.
Stage in advanced cancer
Although everyone had advanced cancer, the point of diagnosis and stage in the disease process varied. Many were diagnosed with advanced cancer at or within a short period of their first contact with cancer services. The length of time that people had lived with advanced disease differed across cancer types. At one end of the spectrum were five patients who were diagnosed between 2 weeks and 9 months prior to interview (renal, bowel, ovarian and lung cancer); at the other were those who had lived with advanced cancer for between 4 and 11 years (four patients all with prostate cancer); the remainder were in-between (breast, head and neck, upper GI).
In characterising types and severity of pain, we have used participants' own accounts. Typically, they employed visceral language and metaphors to differentiate pain texture and intensity.
Complex: multiple, severe and uncontrolled (eight patients).
Here, the multiple sources and types of pain, occurring simultaneously and cumulatively, informed the complexity of the pain experience. Whereas morphine reduced some pain to what was described as a constant 'dull ache', other types of pain -persistent and intermittent -overlaid this with the distinctive features of neuropathic, inflammatory and bony pain as described in the medical literature:
In my hips it's a funny pain, it's more of an ache not a pain, like a dull ache, it's as best I can describe it. This [points to shoulder blade] when I get it is like somebody sticking a knife in you … Most strangest thing that puzzles me is my feet, my toes, numb all the time, these 3, little toe next to it. It's a weird feeling, I get completely numb, I can touch it and you can't feel it, it's just completely dead, and then within 2 minutes it's right, it's annoying it's not painful. (Graham, P21) For others, this type of 'nerve' pain was described as excruciating:
I feel like I've had to bite on something to stop me screaming. Its … like being stabbed, as if I wor being chopped up, like a red hot knife or poker in my legs and knees … I was told it's because the tumour's pressing on a nerve … my left leg when I touch it feels numb, like it belongs to someone else. (Betty, P6)
Where cancer had metastasised to the bone, common in patients with breast and prostate cancer, 'bony' pain overlaid a constant 'dull ache' with an intensity that was uncontrolled by strong opioids. At the first interview, Jenny described new multiple pain sites:
I've lived with this pain in my side now for like 3 weeks and this in my shoulder for nearly 4 weeks. And it's so bad … my skin just feels like somebody's chucked hot water at it, it's, it's just like with radiotherapy, just like burning … they say to me at the hospital it's probably the cancer … that's gone into that particular bone … (Jenny, P3) In her audio diary, she recounted how the X-ray revealed several rib fractures, resulting in pain severity, 'like a 10 plus'. As a consequence she did not want to do anything or go anywhere, could not sleep or lie down and cried 'bucket loads' -from pain and associated low mood. Whereas her regular slow-release opioids kept background pain to an ache, the increased dosage of rescue morphine did not touch this pain. Offered radiotherapy to relieve it, Jenny reported in the second interview that the intensity had reduced somewhat. She anticipated that similar type pain would emerge elsewhere. Aspects of this pain experience were perceived as 'uncontrollable' in persistence and severity, albeit all in this group when interviewed were using a combination of non-opioid analgesics, compound analgesics, slow-release opioids, rescue morphine and anticonvulsants.
Complex: multiple, intermittently severe, partially controlled (eight patients). The predominant feature of pain here was intermittent, oscillating pain, occurring at unpredictable intervals, over a day or days, without identifiable triggers. A typical form of this type of incident pain is illustrated below:
My pain I would say is moderate now … then I get these awful headaches … feels my head is going to explode … and I take the Oromorph then … which helps … I have to have a bottle of that always, otherwise I panic. (Angus, P2)
Less typical was the form described by Ruth:
The pain in the middle of the stomach … It can come and go just as easy, and I've had it last all day and all night … like a griping spasm … It comes to a climax for a second … climaxes like a gripey pain and then it subsides and it makes all these squidgy noises … that varies as to how strong it is … can be excruciating … you dont know where to put yourself …, then 3 minutes later it's doing it again and that can go on anything up to 12 hours and then it just will go and I don't know why, can't follow a pattern at all. (Ruth, P24) Sometimes, but not always, this type of incident pain was relieved with rescue morphine. Lack of consistent experiential evidence that 'rescue morphine' worked resulted in patients and carers questioning its continued use for such pain.
Typically, patients with this type of pain pattern were prescribed a combination of non-opioid analgesia, slowrelease and rescue morphine, although actual use of the latter was inconsistent.
Multiple, simultaneous, low severity, 'controlled' (five patients).
Here, pain intensity was overall low, but punctuated by occasional more intense pain. Such a pattern was reported by patients in the early advanced cancer stage:
There's 2 types really … sometimes I get a really sharp pain and the other sort of pain is like a well it's more ache, a bit like a period pain actually … I feel it in my hips … like pushing down when you're pregnant. (Nicole, P 14)
Although Nicole was prescribed paracetamols and codeine, both were only used when needed, 'sometimes Paracetamols' enough, but if it isn't I take a codeine'.
This pain pattern was also present for patients who were near the end of life and when pain was not a major feature of the cancer. Whereas such patients might have experienced considerable pain leading up to diagnosis and, subsequently, fatigue and weakness, resulting in inactivity meant that pain was not viewed as a problem now, although other symptoms like sickness, diarrhoea or constipation were strongly manifest. Thus, George, whose second interview was around 5 weeks before his death, only got up for a couple of hours during the day:
I can put myself completely out of pain by going and laying down. (George, P9)
At the time of interview, analgesics for this group ranged from paracetamols to weak opioids and rescue morphine. Several had been prescribed opioids during treatment or post-surgery, but had stopped as they considered they had no need of them. From second interviews, it appeared that for some patients here, awareness of subtle shifts in the intensity of intermittent pain was opening up the possibility that medication dose and type might need to be reviewed.
The meanings of pain and help-seeking behaviours
Patients discussed pain in terms of its physical, emotional and existential dimensions, and its impact on what they could do. Accounts of severe, persistent pain adversely affected mood, and inability to secure relief exacerbated sense of loss of control. Pain that was unpredictable had similar emotional impact. Complex pain in its different forms was disruptive of routines that had already narrowed as a result of the cancer. Escalating pain as well as change in type and/or source was perceived as indicative of disease progression, signifying that life was time-limited. The reality was that a new onset of pain at a different site or an increase in severity was often sign of metastatic spread. Consequently, pain was embodied within conflicting emotions and uncertainties. For some patients, this was a potential barrier to seeking support: 24 Sometimes I leave the suffering to the end because I think if I go in with suffering they're going to find something else. Like my chest infection, I think I've got lung cancer when I haven't. Everything I think is connected to my cancer, so when I get pain in an area I think this is it. (Jason, P1) However, although Jason delayed talking about his pain with the oncologist, until the point that he could only walk with difficulty, this precipitated a referral to the hospice for support with pain management.
But focus on pain and the possibility and hope of finding a new means of relieving it could also be a distraction from thoughts of death. At several points during the interview, Max's wife, Eliza, asserted that they were concentrating on getting better pain relief; it was the pain and not the cancer that was 'wiping him out'. When Eliza went out of the room for a moment, he remarked, I'll be honest … I've not told Eliza … she'd get carried away. Since I started on this cancer drug, I'm pretty sure in myself that my back pain has reduced. (Max, P7) At the same time, the association of palliative care with closeness to death was also a barrier for some patients in receiving supportive care for pain.
Processes of pain management
Multiple types of medication delivered in different forms (fentanyl patches, capsule and oral) were the mainstay of pain management for patients experiencing complex, persistent, severe pain. However, pain was not managed in the sense of being controlled. Whereas medication might reduce background pain to a 'dull ache', other types of pain -stabbing pain at unpredictable intervals that could last for extended periods of time, crippling pain running up and down the legs that eased only when sat or lay down, and pins and needles and numbnesswere perceived as unrelieved. Paradoxically, the gap between the multiple types of pain medication and the lack of relief placed a question mark over whether it was worth taking it:
So if I did stop taking them, what would I be like? … Ridiculous that, I could be twice as bad … But obviously I take them because it's erm, well I've been told to take them by the hospital and the doctors so err I do, I do take them as and when I should do. (Bailey, P18)
Patients additionally employed diverse non-pharmacological strategies to secure relief. Betty massaged her legs which eased the pain a little; Dan tried spearmint drinks; Betty and Jenny accessed Reiki at the hospice which although it did not reduce the pain helped them to feel better in themselves.
Patients described a sense of helplessness at their inability to relieve the pain. Being unable to do 'normal' things like get outside to the shops, potter in the garden and being with others affected well-being. The process whereby pain affected mood was spiral: sensory experience contributed to low mood as did inability to do things they enjoyed, exacerbating powerlessness and despair. Caregivers also felt helpless and uncertain in face of unrelieved pain. Dan's wife was torn between wanting to help and unsure as to whether she was doing the right thing:
We do … hot water bottles, in the middle of the night when he wakes in pain and give him a tablet, so … I mean it's hard because you're frightened that you might just give him too many … you see he'd take one, and pain doesn't go, so I was worried of giving another one and I'd say, 'But you can't have another one'. It's like Paracetamols, he'd take them and say, 'Well can I have some more?' and I'm saying, 'No, you can't take any more yet', and of course he wor getting upset 'cos he's saying that I wasn't giving him his medication, 'You're holding it back' and I'd say: 'No, I'm not'. So … Yeah, 'cos I mean you don't like to see anybody in pain, but I just kept thinking you can't give him too much, else it might over … I mean I don't know whether it would have overdosed him or not, but it was … But it wor difficult dealing with it, knowing how much to give him. (Hannah, C17) For patients with intermittently moderate to severe, partially controlled pain, non-opioid analgesia and strong opioids were key resources in relieving it. They also used morphine to manage the rhythm of their day, to maximise what was most important to them: For patients with this pain pattern, rescue morphine was often the first opioid prescribed. Although advised to use it 'as and when needed', dosage and frequency were a source of uncertainty. Dick described 'swigging the bottle' during the night when pain severity stopped him sleeping: I'd no pain for 24 hours … but was sick every half hour for five hours after waking … it was too easy to take. (Dick, P8) He subsequently negotiated with his doctor to go on regular morphine instead.
Side effects of rescue morphine, in context of intermittent pain, had the consequence that use was limited or stopped.
I did take it [Oramorph] sometimes on a night when I was going to bed, but I thought is it worth it? Because it gives me terrible nightmares, I didn't like the nightmares. So I thought well if I can stop taking that and it cures the nightmares, I would rather have the pain. (Harry, P10) Similarly, feeling sleepy and dulled foggy thinking restricted use of rescue morphine in conditions where slow-release opioids were perceived as necessary to manage the pain.
Although our sample represented a range of different types of cancer and trajectories, our data showed that it was the severity of pain that was the distinguishing characteristic which posed implications and consequences for the processes which patients and their families engaged in to manage it.
Discussion
Advanced cancer patients' lives are shaped by their illness, demands of treatment and intrusive symptoms that affect what they can do, of which pain is among the most prevalent. 7 Pain is complex, multi-dimensional and dynamic. [8] [9] [10] [11] How this is experienced and understood by patients and informs pain management practices including use of medication was focus of this study. We highlight three broad patterns of advanced cancer pain that illustrate the variability of pain at this stage. These demonstrate the dynamic, complex and non-linear nature of pain and show how patients' sensory experiences shape the meaning of pain, the strategies employed to manage it and perception of the possibility of achieving control over pain with implications for life quality. For those with severe pain, it was evident that the pain experience was not simply the consequence of 'non-adherence' to prescribed medication; it also reflected the uneven responsiveness of pain complexity to medication, including strong opioids.
Pain complexity aligned with disease progression and the impact of treatments to extend life means that the pain experience is not static but dynamic; developing expertise in its management is not a once-off achievement for patients. Moreover, evaluating and responding optimally to pain complexity also involve professionals in 'trial and error' regarding particular combinations of pharmacological and other therapeutic options.
It was notable that even within a relatively short period of 6 weeks, changes occurred in patients' experience of pain. However, the existential meaning attached to cancer and cancer pain, particularly the fear that pain signals disease progression, could operate to delay patients' communication to professionals about it. Similarly, their association of palliative care with end of life could affect use of specialist pain management support.
While our data showed the presence of a range of beliefs that are reported in the literature as barriers to morphine, 16 ,25-30 they were not central in driving behaviour. Within our sample, the majority of patients reported taking non-opioid analgesics, compound analgesics, strong opioids and slow-release opioids. However, the use of rescue morphine varied depending on patients' sensory experiences of pain. There were several sets of circumstances in which intake of rescue morphine, although prescribed, was limited. There were patients who experienced moderate to severe incident pain which they considered rescue morphine did not touch. Others considered their level of pain could be managed without the use of rescue morphine. Yet others were introduced to opioids for the first time through this mode of delivery, which resulted in physical and cognitive effects regarded as intolerable. For opioid-naive patients 31 particularly, their experiences of adverse effects resulted in limited use or ended use, at least at this stage in their pain. For those who were opioid tolerant but limited their intake of rescue morphine, we posit that this was as a result of the permissiveness of rescue morphine in tandem with a lack of equilibrium in the trade-off between their perceived need for relief and side effects. 11
Limitations
Our study was conducted in one country, and our sample consisted of one ethnic group, which may reflect a specific cultural perspective. However, being located in a tertiary cancer centre with systems in place to effect transition to supportive care for symptom relief alongside non-curative treatment means that patients accessed multiple types and combinations of pharmacological pain relief, as well as radiotherapy. Indeed there was considerable overlap between patients recruited from oncology outpatients and palliative care in their advanced cancer stage. It is possible that our characterisation of pain complexity may not exhaust the types of pain experience in advanced cancer, particularly the process of transition between pain states require further exploration. Despite these limitations, this study has some important strengths. Patients in our sample represented a range of different cancer types, ages and both genders. They had varying levels of pain severity; experienced different types and combinations, from both singular and multiple sites; and used analgesics ranging from occasional paracetamol to a combination of strong opioids. The use of in-depth longitudinal interviews and audio diaries provided us with a richer understanding of the dynamic changes in pain over the illness trajectory. 32 
Conclusion
Advanced cancer pain is dynamic and complex. Patients (and caregivers) assume an active, agentic role in managing pain. Beliefs about analgesics did not drive patient behaviour. Instead, their sensory experiences of pain, particularly of severity, and what they perceived pain to mean drove help-seeking and action to manage it. There are challenges in securing pain relief in relation to different types of pain and their differential responsiveness to medications.
There is a need for more longitudinal research to examine transitions between pain states in advanced cancer and how these are responded to by services and managed by patients, thus taking understanding of pain beyond preoccupation with pain barriers.
